CELGZのチャート
CELGZの企業情報
symbol | CELGZ |
---|---|
会社名 | |
分野(sector) | Health Care ヘルスケア |
産業(industry) | Major Pharmaceuticals |
業種 | ― |
概要 | 事業概要 -- Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include REVLIMID, POMALYST, IMNOVID, OTEZLA, ABRAXANE, and VIDAZA. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. |
本社所在地 | -- |
代表者氏名 | ― |
代表者役職名 | ― |
電話番号 | ― |
設立年月日 | -- |
市場名 | -- |
ipoyear | ―年 |
従業員数 | - |
url | ― |
nasdaq_url | https://www.nasdaq.com/symbol/celgz |
adr_tso | ― |
EBITDA | EBITDA ー |
終値(lastsale) | 1.4 |
時価総額(marketcap) | 0 |
時価総額 | 時価総額 ― |
売上高 | 売上高 -- |
企業価値(EV) | 企業価値(EV) ー |
当期純利益 | 当期純利益 -- |
決算概要 | 決算概要 -- |